Response and resistance to cladribine in patients with advanced systemic mastocytosis: a registry-based analysis.
Sign Up to like & getrecommendations! Published in 2022 at "Annals of hematology"
DOI: 10.1182/blood-2022-163650
Abstract: We sought to evaluate the efficacy of the purine analogue cladribine in 79 patients with advanced systemic mastocytosis (AdvSM) using data from the 'German Registry on Disorders of Eosinophils and Mast Cells (GREM)'. The overall… read more here.
Keywords: cladribine patients; cladribine; patients advanced; systemic mastocytosis ... See more keywords